AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa

Clinical trial NCT02556736 · COMPLETED

Trial details

NCT number: NCT02556736
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Retinitis Pigmentosa

Start date: 2015-12-14
Primary completion: 2020-06-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.